|
|
|
|
|
|
|
Tonix Pharm Hldg (TNXP)
|
|
3.29 0.09 (2.81%)
|
05-22 16:00
|
|
Open:
|
3.1429
|
Pre. Close:
|
3.2
|
|
High:
|
3.3542
|
Low:
|
3.1429
|
|
Volume:
|
40,675
|
Market Cap:
|
28M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
3.355 - 3.369
|
3.369 - 3.382
|
|
Low:
|
3.108 - 3.122
|
3.122 - 3.136
|
|
Close:
|
3.267 - 3.291
|
3.291 - 3.316
|
|
|
|
Technical analysis (as of: 2018-05-22 4:43:29 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 4.08 One year: 4.76
|
|
Support:
|
Support1: 3.00 Support2: 2.70
|
|
Resistance:
|
Resistance1:
3.49 Resistance2: 4.08
|
|
Pivot:
|
2.96 
|
|
Moving Averages:
|
MA(5): 3.08 MA(20): 3.00
MA(100): 3.35  MA(250): 3.73
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): -0.05
|
|
%K %D:
|
%K(14,3): 67.19 %D(3): 49.54
|
|
RSI:
|
RSI(14): 62.81
|
|
52-Week:
|
High: 4.99
Low: 2.7 Change(%): -23.8
|
|
Average Vol(K):
|
3-Month: 6880
10-Days 7880
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.TNXP has closed above the upper band by 11.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 3.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-05-14T12:27:31-04:00
Oryzon Genomics commences mid-stage study of Alzheimer's candidate
2018-05-09T11:51:35-04:00
Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough
2018-05-07T15:09:51-04:00
Tonix: PTSD Breakthrough Or Too Risky For Stockholders?
2018-04-10T12:23:19-04:00
Tonix Pharmaceuticals (TNXP) Presents At MicroCap Conference 2018 - Slideshow
2018-04-04T08:34:21-04:00
Tonix Pharmaceuticals to present PTSD program at the MicroCap Conference in New York
2018-04-03T08:50:39-04:00
Tonix Pharmaceuticals achieves 50% enrollment in Phase 3 trial of Tonmya for the treatment of PTSD
2018-02-13T13:59:47-05:00
Tonix Pharmaceuticals (TNPX) Presents At BIO CEO & Investor Conference - Slideshow
2018-02-09T12:34:12-05:00
Key events next week - healthcare
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
